Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Tuberculosis (TB) remains a major global health concern, further complicated by disruptions in surveillance and management during the COVID-19 pandemic. Emerging evidence positions TB not only as an infectious disease but also as an immune-mediated condition, highlighting the role of host–pathogen interactions in disease persistence. Recent advances in molecular diagnostics, such as metagenomic sequencing, AI-assisted microscopy, and CRISPR-based assays, are transforming early detection and personalized care. At the same time, novel drug regimens for multidrug-resistant TB offer new hope. Integrating host-directed therapies with precision microbiology provides a promising framework for TB control in the post-pandemic era.
Fields of Study & Subjects
Tuberculosis Research and Epidemiology
Infectious Diseases and Tuberculosis
Diagnosis and treatment of tuberculosis
Publication details
- Journal / source
- Revista Alergia México
- Volume
- 73
- Issue
- 1
- Pages
- 109–110
- Publication date
- 31 March 2026
- Language
- EN